[
  {
    "title": "博济医药(300404.SZ)：与远大蜀阳签订5550万元的临床研究委托合同",
    "href": "http://stock.jrj.com.cn/2022/12/27193437241440.shtml",
    "datetime": "2022-12-27 19:34:48",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：第三季度净利651.15万元，同比下降66.08%",
    "href": "http://stock.jrj.com.cn/2022/10/26183937086539.shtml",
    "datetime": "2022-10-26 18:39:43",
    "code": "300404"
  },
  {
    "title": "盘龙药业(002864.SZ)：拟与博济医药签署关于项目PLJT-003的技术委托(开发)合同",
    "href": "http://stock.jrj.com.cn/2022/09/26180937022315.shtml",
    "datetime": "2022-09-26 18:09:56",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：控股股东质押的701万股展期及解质106万股",
    "href": "http://stock.jrj.com.cn/2022/09/23201037018324.shtml",
    "datetime": "2022-09-23 20:10:19",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)半年度净利润1487.69万元 同比增长5.68%",
    "href": "http://stock.jrj.com.cn/2022/08/25224136937857.shtml",
    "datetime": "2022-08-25 22:41:15",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：子公司获得一项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/08/01201436860526.shtml",
    "datetime": "2022-08-01 20:14:52",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)2021年度权益分派10转4派0.2元 股权登记日为6月1日",
    "href": "http://stock.jrj.com.cn/2022/05/25195136678721.shtml",
    "datetime": "2022-05-25 19:51:32",
    "code": "300404"
  },
  {
    "title": "博济医药2022年第一季度净利1246.19万同比增长69.11% 项目进度稳步推进",
    "href": "http://stock.jrj.com.cn/2022/05/03185036546074.shtml",
    "datetime": "2022-05-03 18:50:47",
    "code": "300404"
  },
  {
    "title": "博济医药2021年净利3888.22万同比增长128.87% 董事长王廷春薪酬29.33万",
    "href": "http://stock.jrj.com.cn/2022/04/26225136479243.shtml",
    "datetime": "2022-04-26 22:51:58",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：向86名激励对象授予269.9万份股票期权",
    "href": "http://stock.jrj.com.cn/2022/04/12193836316736.shtml",
    "datetime": "2022-04-12 19:38:13",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：全资子公司通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2022/04/07154636267917.shtml",
    "datetime": "2022-04-07 15:46:35",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：江西博康收到与收益相关的政府补助400万元",
    "href": "http://stock.jrj.com.cn/2022/04/01214336248962.shtml",
    "datetime": "2022-04-01 21:43:07",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：控股子公司获得高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2022/03/25180835126749.shtml",
    "datetime": "2022-03-25 18:08:13",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：近日收到政府补助260.27万元",
    "href": "http://stock.jrj.com.cn/2022/03/23183634870718.shtml",
    "datetime": "2022-03-23 18:36:52",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)拟推270万份股票期权激励计划",
    "href": "http://stock.jrj.com.cn/2022/03/23183334870724.shtml",
    "datetime": "2022-03-23 18:33:21",
    "code": "300404"
  },
  {
    "title": "博济医药净利润预增超一倍 业绩“进三步退两步” 研发投入不突出?",
    "href": "http://stock.jrj.com.cn/2022/01/25083634208596.shtml",
    "datetime": "2022-01-25 08:36:00",
    "code": "300404"
  },
  {
    "title": "博济医药2021年预计净利3700万-4800万同比增长118%-183% 在研项目稳步推进",
    "href": "http://stock.jrj.com.cn/2022/01/24105134201794.shtml",
    "datetime": "2022-01-24 10:51:12",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：2021年度净利预增117.79%-182.54%",
    "href": "http://stock.jrj.com.cn/2022/01/23165634194353.shtml",
    "datetime": "2022-01-23 16:56:42",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：3345.06万股限售股明年1月4日解禁",
    "href": "http://stock.jrj.com.cn/2021/12/29183134082254.shtml",
    "datetime": "2021-12-29 18:31:15",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：控股股东解除质押285万股",
    "href": "http://stock.jrj.com.cn/2021/12/27165234071101.shtml",
    "datetime": "2021-12-27 16:52:10",
    "code": "300404"
  },
  {
    "title": "博济医药聘任左联为副总经理 第三季度公司净利1919.48万",
    "href": "http://stock.jrj.com.cn/2021/12/20215034036852.shtml",
    "datetime": "2021-12-20 21:50:43",
    "code": "300404"
  },
  {
    "title": "博济医药：拟转让子公司相关药物技术成果及知识产权",
    "href": "http://stock.jrj.com.cn/2021/12/20204334036495.shtml",
    "datetime": "2021-12-20 20:43:40",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：签署“硝石甘胆颗粒”《技术转让合同》、《技术开发(委托)合同》等",
    "href": "http://stock.jrj.com.cn/2021/12/20204134036483.shtml",
    "datetime": "2021-12-20 20:41:21",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：酒石酸美托洛尔片获得药品注册证书并将该药品上市许可人100%的权益进行技术转让",
    "href": "http://stock.jrj.com.cn/2021/12/09193633991135.shtml",
    "datetime": "2021-12-09 19:36:02",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：公司通过GLP定期检查并获得《药物GLP认证批件》",
    "href": "http://stock.jrj.com.cn/2021/12/08210133986267.shtml",
    "datetime": "2021-12-08 21:01:59",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：子公司广济投资拟出资3000万元增资入股创钰投资",
    "href": "http://stock.jrj.com.cn/2021/11/19213233882374.shtml",
    "datetime": "2021-11-19 21:32:44",
    "code": "300404"
  },
  {
    "title": "A股异动 | 博济医药(300404.SZ)涨超7% 实控人提前终止股票减持计划",
    "href": "http://stock.jrj.com.cn/2021/11/17102333864791.shtml",
    "datetime": "2021-11-17 10:23:14",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：王廷春及赵伶俐提前终止减持计划 已减持1%的股份",
    "href": "http://stock.jrj.com.cn/2021/11/16200033861672.shtml",
    "datetime": "2021-11-16 20:00:24",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：第三季度净利增152.82%至1919.48万元",
    "href": "http://stock.jrj.com.cn/2021/10/26195633756579.shtml",
    "datetime": "2021-10-26 19:56:33",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：重庆博济近日收到政府补助250万元",
    "href": "http://stock.jrj.com.cn/2021/10/11214233675114.shtml",
    "datetime": "2021-10-11 21:42:44",
    "code": "300404"
  },
  {
    "title": "博济医药控股股东王廷春质押780万股 用于融资",
    "href": "http://stock.jrj.com.cn/2021/09/23194233506184.shtml",
    "datetime": "2021-09-23 19:42:44",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：上半年净利增18.55%至1407.74万元",
    "href": "http://stock.jrj.com.cn/2021/08/25222633319467.shtml",
    "datetime": "2021-08-25 22:26:25",
    "code": "300404"
  },
  {
    "title": "博济医药2021年半年度净利1407.74万元 同比净利增加18.55%",
    "href": "http://stock.jrj.com.cn/2021/08/25210333318896.shtml",
    "datetime": "2021-08-25 21:03:16",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：实控人及其一致行动人拟以集中竞价减持不超1.5%的股份",
    "href": "http://stock.jrj.com.cn/2021/08/06174333213495.shtml",
    "datetime": "2021-08-06 17:43:54",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：全资子公司获得一项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/07/20163833124600.shtml",
    "datetime": "2021-07-20 16:38:59",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：拟使用不超2.2亿元闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/07/05203733048942.shtml",
    "datetime": "2021-07-05 20:37:58",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：拟使用募集资金1.047亿元对科技园公司增资 用于实施募投项目",
    "href": "http://stock.jrj.com.cn/2021/07/05203633048940.shtml",
    "datetime": "2021-07-05 20:36:29",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：实控人及其一致行动人持股比例减少达9.159%",
    "href": "http://stock.jrj.com.cn/2021/06/29214533017738.shtml",
    "datetime": "2021-06-29 21:45:13",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：博济投资拟出资3000万元参投华赢股权投资基金",
    "href": "http://stock.jrj.com.cn/2021/06/29204333017462.shtml",
    "datetime": "2021-06-29 20:43:26",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)披露定增结果：广州高新区投资集团获配877.1929万股",
    "href": "http://stock.jrj.com.cn/2021/06/23170732983592.shtml",
    "datetime": "2021-06-23 17:07:33",
    "code": "300404"
  },
  {
    "title": "博济医药：公司在职员工的数量合计715人",
    "href": "http://stock.jrj.com.cn/2021/06/15143432934140.shtml",
    "datetime": "2021-06-15 14:34:10",
    "code": "300404"
  },
  {
    "title": "博济医药：公司有开展阿尔兹海默症相关药物的临床前研究、临床研究、IND申报等",
    "href": "http://stock.jrj.com.cn/2021/06/15141232934009.shtml",
    "datetime": "2021-06-15 14:12:13",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：获得一项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/06/08180132894531.shtml",
    "datetime": "2021-06-08 18:01:01",
    "code": "300404"
  },
  {
    "title": "博济医药：公司目前暂无在研的ADC药物",
    "href": "http://stock.jrj.com.cn/2021/06/02115832862318.shtml",
    "datetime": "2021-06-02 11:58:28",
    "code": "300404"
  },
  {
    "title": "博济医药：将公司建设成为一家国内领先的大型医药研究服务企业",
    "href": "http://stock.jrj.com.cn/2021/05/24145632810357.shtml",
    "datetime": "2021-05-24 14:56:56",
    "code": "300404"
  },
  {
    "title": "博济医药：在研的中药临床前、临床项目三十余项",
    "href": "http://stock.jrj.com.cn/2021/05/24145432810338.shtml",
    "datetime": "2021-05-24 14:54:02",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2021/05/10160932729869.shtml",
    "datetime": "2021-05-10 16:09:24",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：拟以4842.05万元收购香港永禾44%股权",
    "href": "http://stock.jrj.com.cn/2021/04/18150832393213.shtml",
    "datetime": "2021-04-18 15:08:53",
    "code": "300404"
  },
  {
    "title": "博济医药：公司第四季度营业收入相较去年有所增长但毛利率相较前三季度有所下降",
    "href": "http://stock.jrj.com.cn/2021/03/10143532103314.shtml",
    "datetime": "2021-03-10 14:35:13",
    "code": "300404"
  },
  {
    "title": "博济医药：公司业务的主要增长来源于在手订单的释放等原因",
    "href": "http://stock.jrj.com.cn/2021/03/09154532097780.shtml",
    "datetime": "2021-03-09 15:45:24",
    "code": "300404"
  },
  {
    "title": "博济医药：深圳博瑞承担建设和运营的深圳福田生物医药研发公共服务平台已完成各项准备工作",
    "href": "http://stock.jrj.com.cn/2021/03/09154332097739.shtml",
    "datetime": "2021-03-09 15:43:37",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：年初至今累计获得政府补助453.78万元",
    "href": "http://stock.jrj.com.cn/2021/02/26180932034160.shtml",
    "datetime": "2021-02-26 18:09:58",
    "code": "300404"
  },
  {
    "title": "博济医药：公司承接的创新药项目订单占比近40% 并且开展了八十多个创新药项目",
    "href": "http://stock.jrj.com.cn/2021/02/20111531997072.shtml",
    "datetime": "2021-02-20 11:15:14",
    "code": "300404"
  },
  {
    "title": "[博济医药]袁来如此|大分子生物分析概论(二_1):LBA定量方法的监管验证",
    "href": "http://stock.jrj.com.cn/2021/01/27000031801442.shtml",
    "datetime": "2021-01-27 00:00:00",
    "code": "300404"
  },
  {
    "title": "博济医药2020年预计净利1600万-2080万增长143%-216% 在研项目稳步推进",
    "href": "http://stock.jrj.com.cn/2021/01/26215831780857.shtml",
    "datetime": "2021-01-26 21:58:04",
    "code": "300404"
  },
  {
    "title": "[博济医药]“博济研语”第十六讲:新药开发中的DDI研究!",
    "href": "http://stock.jrj.com.cn/2021/01/21000031801441.shtml",
    "datetime": "2021-01-21 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]博济医药任命孟玉茹博士为博济医药首席科学家",
    "href": "http://stock.jrj.com.cn/2021/01/14000031698857.shtml",
    "datetime": "2021-01-14 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]喜报!重庆博济两江新区国际医药转化中心已启动全面装修,预计下月投入运营",
    "href": "http://stock.jrj.com.cn/2021/01/14000031698856.shtml",
    "datetime": "2021-01-14 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]深圳博瑞福田生物医药研发公共服务平台投入试运营",
    "href": "http://stock.jrj.com.cn/2021/01/13000031688308.shtml",
    "datetime": "2021-01-13 00:00:00",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：15.21万份股票期权可行权",
    "href": "http://stock.jrj.com.cn/2021/01/07165031648551.shtml",
    "datetime": "2021-01-07 16:50:05",
    "code": "300404"
  },
  {
    "title": "[博济医药]博济医药正式任命袁智博士为子公司深圳博瑞医药副总经理",
    "href": "http://stock.jrj.com.cn/2021/01/07000031673806.shtml",
    "datetime": "2021-01-07 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]盘点2020,博济医药年度大事记!",
    "href": "http://stock.jrj.com.cn/2020/12/31000031673805.shtml",
    "datetime": "2020-12-31 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]校企合作续新篇!中国药科大学第三届“博济医药”杯创新创业大赛圆满落幕",
    "href": "http://stock.jrj.com.cn/2020/12/29000031593657.shtml",
    "datetime": "2020-12-29 00:00:00",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：近日收到与收益相关的政府补助资金619万元",
    "href": "http://stock.jrj.com.cn/2020/12/24202131563499.shtml",
    "datetime": "2020-12-24 20:21:37",
    "code": "300404"
  },
  {
    "title": "[博济医药]暨南大学药学院2020级研究生赴博济医药参观学习",
    "href": "http://stock.jrj.com.cn/2020/12/23000031555063.shtml",
    "datetime": "2020-12-23 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]单局挽救7个赛点!博济18周年庆乒乓球赛如此激烈!",
    "href": "http://stock.jrj.com.cn/2020/12/23000031553667.shtml",
    "datetime": "2020-12-23 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]博济医药董事长王廷春受邀出席“2020医药行业领袖闭门会”,与诸多行业领军者共商产业发展大计!",
    "href": "http://stock.jrj.com.cn/2020/12/23000031555060.shtml",
    "datetime": "2020-12-23 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]“博济研语”直播第十三讲:从生物分析角度看影响生物等效性的几点因素",
    "href": "http://stock.jrj.com.cn/2020/12/23000031555062.shtml",
    "datetime": "2020-12-23 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]“博济研语”直播第十二讲:吸入制剂究竟该怎样开发",
    "href": "http://stock.jrj.com.cn/2020/12/23000031553668.shtml",
    "datetime": "2020-12-23 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]男单决赛单局仅赢两分!博济18周年羽毛球赛上演“林李战”",
    "href": "http://stock.jrj.com.cn/2020/12/23000031670484.shtml",
    "datetime": "2020-12-23 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]跨越3000公里山河参赛,监察部东北区荣膺博济18周年篮球赛冠军!",
    "href": "http://stock.jrj.com.cn/2020/12/23000031555061.shtml",
    "datetime": "2020-12-23 00:00:00",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：拟与趣道资管、赣江投资及恒投创业设合伙企业",
    "href": "http://stock.jrj.com.cn/2020/12/10194331458830.shtml",
    "datetime": "2020-12-10 19:43:03",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：拟购买香港永禾44%股权",
    "href": "http://stock.jrj.com.cn/2020/12/10193931458815.shtml",
    "datetime": "2020-12-10 19:39:59",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：定增申请获中国证监会注册批复",
    "href": "http://stock.jrj.com.cn/2020/12/07115031428644.shtml",
    "datetime": "2020-12-07 11:50:59",
    "code": "300404"
  },
  {
    "title": "[博济医药]“博济研语”直播第十一讲:解码改良型创新药物的研究思路!",
    "href": "http://stock.jrj.com.cn/2020/11/04000031510107.shtml",
    "datetime": "2020-11-04 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]博济医药两家子公司共同参与!“创新药注册路径与策略系列沙龙”在张江顺利举行",
    "href": "http://stock.jrj.com.cn/2020/11/02000031510109.shtml",
    "datetime": "2020-11-02 00:00:00",
    "code": "300404"
  },
  {
    "title": "50余家医药生物上市公司集中披露三季报 英科医疗、博济医药等前三季度业绩增幅领先 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/10/28185631151898.shtml",
    "datetime": "2020-10-28 18:56:18",
    "code": "300404"
  },
  {
    "title": "博济医药2020年前三季度净利1946.73万增长247.43% 本期收入利润增加",
    "href": "http://stock.jrj.com.cn/2020/10/28153331150782.shtml",
    "datetime": "2020-10-28 15:33:57",
    "code": "300404"
  },
  {
    "title": "[博济医药]博济医药鼎力支持首届国际肝病药物创新前沿峰会!",
    "href": "http://stock.jrj.com.cn/2020/10/21000031510108.shtml",
    "datetime": "2020-10-21 00:00:00",
    "code": "300404"
  },
  {
    "title": "[博济医药]博济医药团队出席第三届前途汇药品持有人交易博览会",
    "href": "http://stock.jrj.com.cn/2020/10/16000031510110.shtml",
    "datetime": "2020-10-16 00:00:00",
    "code": "300404"
  },
  {
    "title": "博济医药(300404.SZ)：授予74名激励对象250万份股票期权",
    "href": "http://stock.jrj.com.cn/2020/10/15210431062367.shtml",
    "datetime": "2020-10-15 21:04:47",
    "code": "300404"
  },
  {
    "title": "博济医药2020年上半年净利1187.5万增长303.23% 新增合同金额约2.31亿",
    "href": "http://stock.jrj.com.cn/2020/08/31144630643230.shtml",
    "datetime": "2020-08-31 14:46:45",
    "code": "300404"
  },
  {
    "title": "博济医药上半年净利增长303.23% 向创新药研发服务转变",
    "href": "http://stock.jrj.com.cn/2020/08/28100930612099.shtml",
    "datetime": "2020-08-28 10:09:50",
    "code": "300404"
  },
  {
    "title": "博济医药2020年上半年预计净利1150万–1296万 毛利有所上升",
    "href": "http://stock.jrj.com.cn/2020/08/19132630537792.shtml",
    "datetime": "2020-08-19 13:26:09",
    "code": "300404"
  },
  {
    "title": "博济医药：预计上半年净利同比增290.49%–340.07%",
    "href": "http://stock.jrj.com.cn/2020/08/19124530537587.shtml",
    "datetime": "2020-08-19 12:45:00",
    "code": "300404"
  },
  {
    "title": "定增申请被盘问存货情况 博济医药股价连续三日跌停",
    "href": "http://stock.jrj.com.cn/2020/08/19072630534951.shtml",
    "datetime": "2020-08-19 07:26:04",
    "code": "300404"
  },
  {
    "title": "博济医药上半年业绩预增290%-340%",
    "href": "http://stock.jrj.com.cn/2020/08/18221230532825.shtml",
    "datetime": "2020-08-18 22:12:00",
    "code": "300404"
  },
  {
    "title": "定增申请被盘问存货情况 博济医药股价连续三跌停",
    "href": "http://stock.jrj.com.cn/2020/08/18213130532556.shtml",
    "datetime": "2020-08-18 21:31:00",
    "code": "300404"
  },
  {
    "title": "定增申请被盘问存货情况 博济医药股价连续三跌停",
    "href": "http://stock.jrj.com.cn/2020/08/18213130579435.shtml",
    "datetime": "2020-08-18 21:31:00",
    "code": "300404"
  },
  {
    "title": "博济医药：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/08/18202030532012.shtml",
    "datetime": "2020-08-18 20:20:00",
    "code": "300404"
  },
  {
    "title": "【龙虎榜】博济医药8月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/18180530531178.shtml",
    "datetime": "2020-08-18 18:05:32",
    "code": "300404"
  },
  {
    "title": "【龙虎榜】博济医药8月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/17180530520606.shtml",
    "datetime": "2020-08-17 18:05:55",
    "code": "300404"
  },
  {
    "title": "博济医药一字跌停 富兴投资旗下私募为第9大流通股东",
    "href": "http://stock.jrj.com.cn/2020/08/17132730518751.shtml",
    "datetime": "2020-08-17 13:27:00",
    "code": "300404"
  },
  {
    "title": "博济医药王廷春：无问医药，只为创新",
    "href": "http://stock.jrj.com.cn/2020/08/04073630419552.shtml",
    "datetime": "2020-08-04 07:36:24",
    "code": "300404"
  },
  {
    "title": "快讯：博济医药急速拉升7.48% 主力资金净流入417.82万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/23103329996637.shtml",
    "datetime": "2020-06-23 10:33:00",
    "code": "300404"
  },
  {
    "title": "博济医药收入异常增加遭深交所问询 七成利润来自政府补贴出路何在？",
    "href": "http://stock.jrj.com.cn/2020/06/10081729886482.shtml",
    "datetime": "2020-06-10 08:17:07",
    "code": "300404"
  },
  {
    "title": "博济医药股东王廷春质押710.6万股 用于融资",
    "href": "http://stock.jrj.com.cn/2020/05/04140129531891.shtml",
    "datetime": "2020-05-04 14:01:32",
    "code": "300404"
  },
  {
    "title": "博济医药聘任欧秀清为公司副总经理兼财务总监",
    "href": "http://stock.jrj.com.cn/2020/04/24231829370730.shtml",
    "datetime": "2020-04-24 23:18:03",
    "code": "300404"
  },
  {
    "title": "博济医药第一季度亏损586.31万 较上年同期由盈转亏",
    "href": "http://stock.jrj.com.cn/2020/04/24100829364786.shtml",
    "datetime": "2020-04-24 10:08:33",
    "code": "300404"
  },
  {
    "title": "博济医药：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/10085029253915.shtml",
    "datetime": "2020-04-10 08:50:01",
    "code": "300404"
  },
  {
    "title": "博济医药：子公司获药物临床试验默示许可",
    "href": "http://stock.jrj.com.cn/2020/03/24161529094949.shtml",
    "datetime": "2020-03-24 16:15:18",
    "code": "300404"
  },
  {
    "title": "博济医药：子公司获得药物临床试验默示许可",
    "href": "http://stock.jrj.com.cn/2020/03/24160129094926.shtml",
    "datetime": "2020-03-24 16:01:00",
    "code": "300404"
  },
  {
    "title": "博济医药：拟定增募资不超3.43亿元",
    "href": "http://stock.jrj.com.cn/2020/03/09184428981652.shtml",
    "datetime": "2020-03-09 18:44:20",
    "code": "300404"
  },
  {
    "title": "博济医药拟建设深圳福田生物医药研发公共服务平台项目",
    "href": "http://stock.jrj.com.cn/2020/03/03104928943079.shtml",
    "datetime": "2020-03-03 10:49:22",
    "code": "300404"
  },
  {
    "title": "博济医药：拟投建深圳福田生物医药研发公共服务平台项目",
    "href": "http://stock.jrj.com.cn/2020/03/02203028936183.shtml",
    "datetime": "2020-03-02 20:30:08",
    "code": "300404"
  },
  {
    "title": "博济医药：拟建设深圳福田生物医药研发公共服务平台项目",
    "href": "http://stock.jrj.com.cn/2020/03/02201428936121.shtml",
    "datetime": "2020-03-02 20:14:00",
    "code": "300404"
  },
  {
    "title": "博济医药：拟出资8000万元投资建设生物医药研发公共服务平台",
    "href": "http://stock.jrj.com.cn/2020/03/02200928936146.shtml",
    "datetime": "2020-03-02 20:09:00",
    "code": "300404"
  },
  {
    "title": "博济医药2019年净利631万下滑15% 公司加大自主研发投入",
    "href": "http://stock.jrj.com.cn/2020/02/29124028919339.shtml",
    "datetime": "2020-02-29 12:40:39",
    "code": "300404"
  },
  {
    "title": "博济医药：协助多项针对新冠肺炎药物和医疗器械研究",
    "href": "http://stock.jrj.com.cn/2020/02/17164128839662.shtml",
    "datetime": "2020-02-17 16:41:00",
    "code": "300404"
  },
  {
    "title": "博济医药：子公司参与的新冠肺炎临床研究获伦理审批",
    "href": "http://stock.jrj.com.cn/2020/02/12213828817859.shtml",
    "datetime": "2020-02-12 21:38:00",
    "code": "300404"
  },
  {
    "title": "博济医药子公司助力钟南山院士牵头的新冠肺炎临床研究获伦理审批",
    "href": "http://stock.jrj.com.cn/2020/02/12180128816649.shtml",
    "datetime": "2020-02-12 18:01:00",
    "code": "300404"
  },
  {
    "title": "钟南山牵头的NCP临床研究通过伦理审评 博济医药提供CRO服务",
    "href": "http://stock.jrj.com.cn/2020/02/12153528815902.shtml",
    "datetime": "2020-02-12 15:35:40",
    "code": "300404"
  },
  {
    "title": "博济医药—九泰药械助力钟南山院士牵头项目获审批，或将有助于抗击疫情！",
    "href": "http://stock.jrj.com.cn/2020/02/04150328767111.shtml",
    "datetime": "2020-02-04 15:03:25",
    "code": "300404"
  },
  {
    "title": "博济医药：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/23205028729137.shtml",
    "datetime": "2020-01-23 20:50:00",
    "code": "300404"
  },
  {
    "title": "博济医药2019年度预计净利620万元–806万元 与上年同期基本持平",
    "href": "http://stock.jrj.com.cn/2020/01/23203128729084.shtml",
    "datetime": "2020-01-23 20:31:10",
    "code": "300404"
  },
  {
    "title": "博济医药：拟在南昌科创城建设中医药产业平台",
    "href": "http://stock.jrj.com.cn/2020/01/10184628659100.shtml",
    "datetime": "2020-01-10 18:46:00",
    "code": "300404"
  },
  {
    "title": "博济医药与科创城管委会签订合同 拟共建中医药产业平台",
    "href": "http://stock.jrj.com.cn/2020/01/09184828651424.shtml",
    "datetime": "2020-01-09 18:48:18",
    "code": "300404"
  },
  {
    "title": "博济医药：与南昌科创城管委会签订项目进区合同 拟共同打造中医药产业平台",
    "href": "http://stock.jrj.com.cn/2020/01/09174028650725.shtml",
    "datetime": "2020-01-09 17:40:37",
    "code": "300404"
  },
  {
    "title": "博济医药股东王廷春减持485万股 套现约1.23亿元",
    "href": "http://stock.jrj.com.cn/2019/11/05182528355260.shtml",
    "datetime": "2019-11-05 18:25:47",
    "code": "300404"
  },
  {
    "title": "博济医药第三季度盈利266万 同比增长588.26%",
    "href": "http://stock.jrj.com.cn/2019/10/29132028317324.shtml",
    "datetime": "2019-10-29 13:20:53",
    "code": "300404"
  },
  {
    "title": "博济医药董事会秘书韩宇萍辞职 2018年薪酬为53万元",
    "href": "http://stock.jrj.com.cn/2019/10/29092428315975.shtml",
    "datetime": "2019-10-29 09:24:00",
    "code": "300404"
  },
  {
    "title": "博济医药：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/15022028246134.shtml",
    "datetime": "2019-10-15 02:20:00",
    "code": "300404"
  },
  {
    "title": "博济医药2019年前三季度净利约490万元-613万元 毛利率有所降低",
    "href": "http://stock.jrj.com.cn/2019/10/14185828244636.shtml",
    "datetime": "2019-10-14 18:58:00",
    "code": "300404"
  },
  {
    "title": "博济医药：实控人在26日通过集中竞价减持9500股",
    "href": "http://stock.jrj.com.cn/2019/09/30181128201565.shtml",
    "datetime": "2019-09-30 18:11:46",
    "code": "300404"
  },
  {
    "title": "博济医药：与珠海藤栢就抗肿瘤新药临床试验技术服务达成合作",
    "href": "http://stock.jrj.com.cn/2019/09/17190228141585.shtml",
    "datetime": "2019-09-17 19:02:00",
    "code": "300404"
  },
  {
    "title": "博济医药使用8000万元闲置自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2019/08/28140828048809.shtml",
    "datetime": "2019-08-28 14:08:04",
    "code": "300404"
  },
  {
    "title": "博济医药2019年上半年净利295万 订单状况良好",
    "href": "http://stock.jrj.com.cn/2019/08/27221328043369.shtml",
    "datetime": "2019-08-27 22:13:26",
    "code": "300404"
  },
  {
    "title": "博济医药与西安新通签订《技术开发(委托)合同》 合同金额9583万元",
    "href": "http://stock.jrj.com.cn/2019/08/21080128008269.shtml",
    "datetime": "2019-08-21 08:01:18",
    "code": "300404"
  },
  {
    "title": "博济医药受托开发治疗慢性乙肝新药：研发经费9583万 研发期限4年半",
    "href": "http://stock.jrj.com.cn/2019/08/20174528005731.shtml",
    "datetime": "2019-08-20 17:45:45",
    "code": "300404"
  },
  {
    "title": "博济医药：签订9583万元技术开发（委托）合同",
    "href": "http://stock.jrj.com.cn/2019/08/20155428004726.shtml",
    "datetime": "2019-08-20 15:54:00",
    "code": "300404"
  },
  {
    "title": "博济医药：签订9583万元药品技术开发合同",
    "href": "http://stock.jrj.com.cn/2019/08/20154828004879.shtml",
    "datetime": "2019-08-20 15:48:00",
    "code": "300404"
  },
  {
    "title": "博济医药2019年上半年净利201万–373万 研发费用有所增加",
    "href": "http://stock.jrj.com.cn/2019/07/13083127836021.shtml",
    "datetime": "2019-07-13 08:31:30",
    "code": "300404"
  },
  {
    "title": "博济医药：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/12225027834434.shtml",
    "datetime": "2019-07-12 22:50:00",
    "code": "300404"
  },
  {
    "title": "博济医药去年净利740万同比增长130% 董事长王廷春薪酬为26万元",
    "href": "http://stock.jrj.com.cn/2019/04/29232227509784.shtml",
    "datetime": "2019-04-29 23:22:35",
    "code": "300404"
  },
  {
    "title": "博济医药：延期披露定期报告",
    "href": "http://stock.jrj.com.cn/2019/04/26155827491593.shtml",
    "datetime": "2019-04-26 15:58:05",
    "code": "300404"
  },
  {
    "title": "博济医药：拟在新乡高新区打造生物医药产业基地",
    "href": "http://stock.jrj.com.cn/2019/04/22185627456194.shtml",
    "datetime": "2019-04-22 18:56:54",
    "code": "300404"
  },
  {
    "title": "博济医药一季度净利预降50%–80% 控股股东拟减持3%",
    "href": "http://stock.jrj.com.cn/2019/04/11074427364854.shtml",
    "datetime": "2019-04-11 07:44:51",
    "code": "300404"
  },
  {
    "title": "博济医药：实控人拟减持不超3%股权",
    "href": "http://stock.jrj.com.cn/2019/04/09185727355927.shtml",
    "datetime": "2019-04-09 18:57:00",
    "code": "300404"
  },
  {
    "title": "博济医药：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/08202027347916.shtml",
    "datetime": "2019-04-08 20:20:00",
    "code": "300404"
  },
  {
    "title": "上市公司晚间利空公告：博济医药股东拟减持4.38％股份",
    "href": "http://stock.jrj.com.cn/2019/03/05174327121506.shtml",
    "datetime": "2019-03-05 17:43:10",
    "code": "300404"
  },
  {
    "title": "博济医药：达晨创世和达晨盛世减持公司4.38%股份",
    "href": "http://stock.jrj.com.cn/2019/03/05165927121254.shtml",
    "datetime": "2019-03-05 16:59:43",
    "code": "300404"
  },
  {
    "title": "博济医药：股东达晨创世和达晨盛世拟合计减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/02/20175527067254.shtml",
    "datetime": "2019-02-20 17:55:00",
    "code": "300404"
  },
  {
    "title": "博济医药遭达晨系减持134万股 去年利润600万至1100 万",
    "href": "http://stock.jrj.com.cn/2019/02/11222127029665.shtml",
    "datetime": "2019-02-11 22:21:00",
    "code": "300404"
  },
  {
    "title": "博济医药2018年扭亏为盈：净利最高1100万元 毛利率有所上升",
    "href": "http://stock.jrj.com.cn/2019/01/31232027009970.shtml",
    "datetime": "2019-01-31 23:20:28",
    "code": "300404"
  },
  {
    "title": "博济医药：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/31000027004411.shtml",
    "datetime": "2019-01-31 00:00:01",
    "code": "300404"
  },
  {
    "title": "博济医药：股东达晨创世及达晨盛世减持公司1％股份",
    "href": "http://stock.jrj.com.cn/2019/01/22213226943049.shtml",
    "datetime": "2019-01-22 21:32:02",
    "code": "300404"
  },
  {
    "title": "博济医药：达晨创世及达晨盛世减持公司0.403%股份",
    "href": "http://stock.jrj.com.cn/2018/12/27182126813491.shtml",
    "datetime": "2018-12-27 18:21:41",
    "code": "300404"
  },
  {
    "title": "博济医药：获得发明专利证书",
    "href": "http://stock.jrj.com.cn/hotstock/2018/12/26080026803438.shtml",
    "datetime": "2018-12-26 08:00:01",
    "code": "300404"
  },
  {
    "title": "博济医药：全资子公司拟1000万参与设立股权投资基金",
    "href": "http://stock.jrj.com.cn/2018/12/04162325448524.shtml",
    "datetime": "2018-12-04 16:23:10",
    "code": "300404"
  },
  {
    "title": "博济医药：股东达晨创世及达晨盛世拟合计减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2018/11/02201625298668.shtml",
    "datetime": "2018-11-02 20:16:00",
    "code": "300404"
  },
  {
    "title": "博济医药两股东拟合计减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2018/11/02195325298613.shtml",
    "datetime": "2018-11-02 19:53:37",
    "code": "300404"
  },
  {
    "title": "博济医药获得政府补助资金998.6万元",
    "href": "http://stock.jrj.com.cn/2018/10/25212825260437.shtml",
    "datetime": "2018-10-25 21:28:49",
    "code": "300404"
  },
  {
    "title": "博济医药：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/12212025197376.shtml",
    "datetime": "2018-10-12 21:20:00",
    "code": "300404"
  },
  {
    "title": "博济医药：GMP认证相关工作正在按计划推进中",
    "href": "http://stock.jrj.com.cn/2018/10/11150025187660.shtml",
    "datetime": "2018-10-11 15:00:00",
    "code": "300404"
  },
  {
    "title": "博济医药：收到政府专项补助资金670万元",
    "href": "http://stock.jrj.com.cn/2018/09/25173625135774.shtml",
    "datetime": "2018-09-25 17:36:17",
    "code": "300404"
  },
  {
    "title": "博济医药董秘：博济药物检测中心通过中国合格评定国家认可委员会认可",
    "href": "http://stock.jrj.com.cn/2018/07/25185024863166.shtml",
    "datetime": "2018-07-25 18:50:00",
    "code": "300404"
  },
  {
    "title": "博济医药：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/07/13202024814354.shtml",
    "datetime": "2018-07-13 20:20:00",
    "code": "300404"
  },
  {
    "title": "博济医药：合资公司参与运营抗肿瘤化药1类新药RUNNOR9591",
    "href": "http://stock.jrj.com.cn/2018/05/16000524544426.shtml",
    "datetime": "2018-05-16 00:05:00",
    "code": "300404"
  },
  {
    "title": "订单持续增长 博济医药业绩复苏",
    "href": "http://stock.jrj.com.cn/2018/05/15223724544297.shtml",
    "datetime": "2018-05-15 22:37:03",
    "code": "300404"
  },
  {
    "title": "博济医药业绩大变脸引造假质疑",
    "href": "http://stock.jrj.com.cn/2018/05/15063924538750.shtml",
    "datetime": "2018-05-15 06:39:00",
    "code": "300404"
  },
  {
    "title": "博济医药一季度营收和利润齐增逾两倍",
    "href": "http://stock.jrj.com.cn/2018/04/25234524452409.shtml",
    "datetime": "2018-04-25 23:45:16",
    "code": "300404"
  },
  {
    "title": "硅谷天堂拟与博济医药设医药研发基金 规模2亿元",
    "href": "http://stock.jrj.com.cn/2018/04/25175924451315.shtml",
    "datetime": "2018-04-25 17:59:00",
    "code": "300404"
  },
  {
    "title": "启动线上阿里医务室 医药板块强势",
    "href": "http://stock.jrj.com.cn/2018/04/25151224449669.shtml",
    "datetime": "2018-04-25 15:12:38",
    "code": "300404"
  },
  {
    "title": "医疗器械板块强势拉升 博济医药涨停",
    "href": "http://stock.jrj.com.cn/2018/04/25150024449617.shtml",
    "datetime": "2018-04-25 15:00:16",
    "code": "300404"
  },
  {
    "title": "博济医药持股5%以上股东计划减持不超过800万股",
    "href": "http://stock.jrj.com.cn/2018/04/13175824387951.shtml",
    "datetime": "2018-04-13 17:58:00",
    "code": "300404"
  },
  {
    "title": "博济医药股东拟合计减持不超5.96%股份",
    "href": "http://stock.jrj.com.cn/2018/04/13173924387813.shtml",
    "datetime": "2018-04-13 17:39:33",
    "code": "300404"
  },
  {
    "title": "博济医药：股东拟合计减持不超5.96%股份",
    "href": "http://stock.jrj.com.cn/2018/04/13172524387708.shtml",
    "datetime": "2018-04-13 17:25:00",
    "code": "300404"
  },
  {
    "title": "博济医药一季度业绩预计扭亏为盈",
    "href": "http://stock.jrj.com.cn/2018/04/09232124364868.shtml",
    "datetime": "2018-04-09 23:21:34",
    "code": "300404"
  },
  {
    "title": "博济医药旗下产业基金收购国信医药51%股权",
    "href": "http://stock.jrj.com.cn/2018/03/20223524269304.shtml",
    "datetime": "2018-03-20 22:35:51",
    "code": "300404"
  },
  {
    "title": "博济医药：2017年费用上升 净利亏损2719万元",
    "href": "http://stock.jrj.com.cn/2018/02/14172524119687.shtml",
    "datetime": "2018-02-14 17:25:00",
    "code": "300404"
  },
  {
    "title": "博济医药：收到科技发展专项资金180万元",
    "href": "http://stock.jrj.com.cn/hotstock/2017/12/22075923834897.shtml",
    "datetime": "2017-12-22 07:59:55",
    "code": "300404"
  },
  {
    "title": "[哈药股份]博济医药遭股东减持700万股",
    "href": "http://stock.jrj.com.cn/2017/02/23000024834655.shtml",
    "datetime": "2017-02-23 00:00:00",
    "code": "300404"
  },
  {
    "title": "[哈药股份]博济医药遭股东减持700万股",
    "href": "http://stock.jrj.com.cn/2017/02/23000031006402.shtml",
    "datetime": "2017-02-23 00:00:00",
    "code": "300404"
  },
  {
    "title": "博济医药中报净利亏损168万元 同比减少113.56％",
    "href": "http://stock.jrj.com.cn/2016/08/26180021377195.shtml",
    "datetime": "2016-08-26 18:00:48",
    "code": "300404"
  },
  {
    "title": "快讯：医疗保健板块午后走强 博济医药上涨逾6%",
    "href": "http://stock.jrj.com.cn/2016/05/17133020966226.shtml",
    "datetime": "2016-05-17 13:30:57",
    "code": "300404"
  },
  {
    "title": "本批最后5只新股今日申购 博济医药期待较高",
    "href": "http://stock.jrj.com.cn/ipo/2015/04/16061719105794.shtml",
    "datetime": "2015-04-16 06:17:54",
    "code": "300404"
  }
]